Related Experiment Video
Updated: Jan 25, 2026

A Technique for Subcutaneous Abdominal Adipose Tissue Biopsy via a Non-diathermy Method
Published on: September 30, 2017
Takotsubo cardiomyopathy following unintentionally large subcutaneous adrenaline injection: a case report
Roberto Spina1, Ning Song1, Krishna Kathir1
1Department of Interventional Cardiology, St Vincent's Hospital, Sydney, Australia.
Insights
Excessive catecholamine secretion, particularly from exogenous adrenaline administration during local anesthesia, can trigger stress cardiomyopathy (takotsubo syndrome). This case highlights the importance of careful dosing to prevent adverse cardiac events.
Area of Science:
- Cardiology
- Anesthesiology
- Pharmacology
Background:
- Stress cardiomyopathy, or takotsubo syndrome, involves temporary left ventricular dysfunction without coronary artery disease.
- Proposed mechanisms include vasospasm, microcirculatory issues, and catecholamine excess.
Observation:
- A patient developed severe hypertension, tachycardia, and ECG changes post-local anesthesia for skin cancer removal.
- Cardiac catheterization showed no obstructive coronary disease; ventriculography revealed takotsubo syndrome.
- An unintentional 4mg subcutaneous adrenaline dose was administered with lignocaine.
Findings:
- This case provides direct evidence linking excess catecholamine secretion to takotsubo syndrome.
- Literature review confirms associations with exogenous (e.g., adrenaline) and endogenous (e.g., pheochromocytoma) catecholamines.
- Adrenaline in local anesthesia is common, necessitating careful concentration management.
Implications:
- Clinicians should use the lowest effective adrenaline concentration in local anesthesia to mitigate takotsubo syndrome risk.
- Understanding catecholamine's role is crucial for preventing iatrogenic cardiac events.
- This emphasizes the need for vigilance in medication administration during surgical procedures.
Introduction:
Stress cardiomyopathy, also known as takotsubo syndrome, is characterized by transient left ventricular dysfunction not attributable to obstructive epicardial coronary artery disease. Several pathological mechanisms have been proposed, including multivessel coronary artery vasospasm, coronary microcirculatory dysfunction, and excess catecholamine secretion.
Case Presentation:
A 68-year-old male presented to our institution for elective surgical removal of a cutaneous basal cell carcinoma on the right side of his face. Within minutes following the administration of local anaesthesia, the patient developed severe hypertension, tachycardia, ST-segment elevation on the electrocardiogram, and non-sustained broad-complex tachycardia. Urgent cardiac catheterization revealed non-obstructive coronary artery disease and left ventriculography demonstrated apical hypokinesia and moderate systolic dysfunction consistent with the takotsubo syndrome. On review of the medications administered, it was noted that an unintentionally large dose of adrenaline (4mg) had been injected subcutaneously with lignocaine. He was monitored in the coronary care and recovered fully with supportive care only. Bisoprolol was initiated on day 1 post procedure. On follow-up one month later, his left ventricular function had normalized.
Discussion:
Our case report provides direct evidence supporting the pathogenetic role of excess catecholamine secretion in the development of the takotsubo syndrome. A review of the literature reveals that both exogenous catecholamine administration (adrenaline injection in the context of anaphylaxis or infiltrative anaesthesia) and excess endogenous catecholamine (phaechromocytoma) secretion has been associated with the takotsubo syndrome. Local infiltrative anaesthesia with the addition of adrenaline is commonly used as a vasoconstrictor in a wide variety of surgical procedures. To reduce the risk of adverse events, the lowest effective concentration of adrenaline to provide pain control and vasoconstriction is recommended.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

